相关实验视频

Updated: Jan 17, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

重组三桑丁载荷纳米粒子具有瘤向和细胞透能力,用于可激活的抗瘤疗法

Lian-Hua Fu¹, Minghuan Zhang², Zeyao Zhu³

¹Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China.

ACS applied materials & interfaces

|September 23, 2025

概括

带有类的工程三桑 (TCS),并装入pH响应的纳米颗粒中,增强了癌细胞的亡. 这种新型的输送系统提高了瘤的特异性和细胞透率,以有效治疗癌症.

科学领域:

生物化学生物化学
纳米技术纳米技术
在瘤学瘤学.

背景情况:

三桑丁 (TCS) 是一种诱导癌细胞死亡的核糖体失活蛋白,但缺乏瘤特异性和细胞透性.
开发有针对性的药物输送系统对于提高TCS等细胞毒剂的疗效至关重要.

研究的目的:

设计一种新的TCS重组融合蛋白 (rTLM),具有向和细胞透的部分.
为rTLM开发一个pH响应的纳米粒子传递系统 (BSA-MnCaP),增强瘤向和受控释放.
在体外和体内评估BSA-MnCaP-rTLM系统的协同抗瘤效应.

主要方法:

通过将低分子量原胺 (LMWP) 和矩阵金属蛋白酶选择性 (MSP) 插入TCS.中,构建了一个重组融合蛋白 (rTCS-LMWP-MSP,rTLM).
制造的配合酸 (MnCaP) 纳米颗粒,用牛血清白蛋白 (BSA) 为模板,用于对pH反应的药物输送.
通过体外和体外实验研究了BSA-MnCaP-rTLM的瘤向,细胞透和协同抗瘤作用.

主要成果:

设计的rTLM表现出增强的瘤向和细胞透能力.
在酸性瘤微环境中,BSA-MnCaP纳米颗粒证明了rTLM的pH响应释放.
组合系统 (BSA-MnCaP-rTLM) 显示出协同作用的抗瘤作用,诱导癌细胞的亡和氧化应激.
从纳米颗粒中释放的离子催化了类似芬顿的反应,产生基激素并增强氧化应激.

结论:

BSA-MnCaP-rTLM系统有效地克服了TCS的局限性,提供了改善的瘤特异性和细胞吸收.
响应pH的纳米粒子传递系统增强了生物相容性,并使目标有效载荷释放成为可能.
这种新型纳米药物通过联合诱导亡和氧化应激促进,具有有效癌症治疗的巨大潜力.

关键词:

酸纳米粒子酸纳米粒子癌症治疗疗法癌症治疗通过细胞透.再组合的三三胺.针对瘤的向定位.

更多相关视频

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.